First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-11-18 22:42:20Open Document File Size: 884,00 KBShare Result on FacebookCityMelbourne / Sydney / Stockholm / /CompanyNSW Therapeutic Advisory Group / Therapeutic Guidelines Limited / Bajorek BV / /CountryAustralia / /FacilityNational Institute of Clinical Studies / /IndustryTermstroke prevention / data collection tool / /MedicalConditionD Diabetes / hypertension / nonvalvular atrial fibrillation / V Vascular disease / stroke / Cirrhosis / thromboembolism / S2 Stroke/Transient Ischaemic Attack/Thromboembolism / prior myocardial infarction / Renal Disease / peripheral artery disease / atrial fibrillation / C Congestive heart failure/left ventricular dysfunction / H Hypertension / Liver Disease / transient ischemic attacks / /MedicalTreatmentpharmacotherapy / Dialysis / /OrganizationAustralian Commission / European Society of Cardiology / /PositionGovernor / physician / Major / /ProductIrbesartan / Denominator / If / vitamin K / Clopidogrel / The Medication / /ProvinceOrStateMaryland / /TechnologyDialysis / /URLwww.cec.health.nsw.gov.au / /SocialTag |